Use of bone‐modifying agents and clinical outcomes in older adults with multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of bone‐modifying agents and clinical outcomes in older adults with multiple myeloma

Published:2019-09-30 Issue:16 Volume:8 Page:6945-6954
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Olszewski Adam J.¹²^ORCID,Barth Peter M.¹²^ORCID,Reagan John L.¹²^ORCID

Affiliation:

1. Alpert Medical School of Brown University Providence RI USA

2. Division of Hematology‐Oncology Lifespan Cancer Institute Providence RI USA

Funder

American Cancer Society

California Department of Public Health

National Cancer Institute

University of Southern California

Centers for Disease Control and Prevention

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2591

Reference39 articles.

1. Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

2. A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma

3. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

4. Bisphosphonates in multiple myeloma: a network meta‐analysis;Mhaskar R;Cochrane Database Syst Rev,2012

5. Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of immunomodulatory drugs on bone metabolism of patients with multiple myeloma;Expert Review of Hematology;2024-02-12

2. Atypical presentation of medication-related osteonecrosis of the jaw in a young male patient undergoing chemotherapy for acute lymphoblastic leukemia;Oral Oncology Reports;2023-12

3. Multiple-Drugs-Related Osteonecrosis of the Jaw in a Patient Affected by Multiple Myeloma: A Case Report;Dentistry Journal;2023-04-13

4. Outcomes of lenalidomide‐ or bortezomib‐based regimens in older patients with plasma cell myeloma;American Journal of Hematology;2020-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3